Andrea K. Ng, MD, MPH

home / authors / andrea-k-ng-md-mph

Articles

$The Evolving Role of Radiation Therapy in DLBCL: From Early-Stage to Refractory Disease$

The Evolving Role of Radiation Therapy in DLBCL: From Early-Stage to Refractory Disease

Gavin Jones, MD;John P. Plastaras, MD, PhD;Andrea K. Ng, MD, MPH;Chris R. Kelsey, MD

December 21st 2022

Gavin Jones, MD, and colleagues explore the landscape of radiation therapy in diffuse large B-cell lymphoma.

Controversies in Early-Stage Hodgkin’s Disease

Andrea K. Ng, MD, MPH;Peter M. Mauch, MD

May 1st 2002

Early-stage Hodgkin’s disease accounts for approximately 60% of all cases of the illness. Because of its excellent cure rate (80% to 90%) and high salvage rate, it is difficult to demonstrate survival advantages for

Latest Updated Articles

Published: September 13th 2024 | Updated: November 25th 2024

Non–clear Cell RCC: First-Line Treatment Options and Guideline Updates

NSABP B-42 trial results show that the assay was predictive of extended letrozole therapy response, identifying a patient subset with improved outcomes.

Published: August 9th 2024 | Updated: August 14th 2024

Gene Assay May Predict Extended Letrozole Benefits in Breast Cancer Subsets

Published: June 2nd 2024 | Updated: June 3rd 2024

OS Prolonged With Perioperative Chemo Vs Neoadjuvant CRT in Esophageal Cancer

Data from the CheckMate-67T trial support the biologics license application for subcutaneous nivolumab in multiple solid tumors.

Published: May 6th 2024 | Updated: May 21st 2024

FDA Accepts BLA for Subcutaneous Nivolumab in Solid Tumor Indications

Published: May 13th 2013 | Updated: December 26th 2024

A 49-Year-Old Woman Develops Thickened and Bound-Down Skin

Published: May 17th 2013 | Updated: December 26th 2024

Lower Back Pain in an Elderly Man With a History of Localized Prostate Cancer

Do Not Sell My Personal Information

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777